General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-08-13 | 2024-06 | -0.04 | N/A | N/A | N/A |
2024-05-07 | 2024-03 | -0.07 | -0.05 | 0.02 | 28.57% |
2024-03-12 | 2023-12 | -0.18 | -0.12 | 0.06 | 33.33% |
2024-03-12 | 2023-12 | -0.18 | N/A | N/A | N/A |
2023-11-06 | 2023-09 | -0.1 | -0.09 | 0.01 | 10.00% |
2023-11-06 | 2023-09 | -0.1 | N/A | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-10 | Citigroup | Upgrade | Neutral | Neutral |
2023-03-05 | Canaccord Genuity | Upgrade | Buy | |
2023-03-05 | Credit Suisse | Upgrade | Underperform | |
2022-11-15 | Citigroup | Upgrade | Neutral | |
2022-11-07 | SVB Leerink | Upgrade | Market Perform | |
2022-08-08 | Citigroup | Upgrade | Neutral |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-01-02 | CLINTON CHELSEA | Director | 541.84K | Stock Award(Grant) |
2024-01-02 | EDWARDS CARLADENISE ARMBRISTER | Director | 412.25K | Stock Award(Grant) |
2024-01-04 | GARIPALLI VIVEK | Director and Beneficial Owner of more than 10% of a Class of Security | 0.00 | Conversion of Exercise of derivative security |
2024-01-02 | KOUZOUKAS DEMETRIOS L | Director | 465.64K | Stock Award(Grant) |
2023-10-30 | LEFFLER SCOTT J. | Chief Technology Officer | 3.09M | Stock Award(Grant) |
2024-05-16 | LOENGARD ANNA U | Director | 0.00 | Purchase |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 31.43M | 28.20M | 7.92% |
2023-06-29 | Renaissance Technologies, LLC | 8.85M | 7.94M | 2.23% |
2023-06-29 | Blackrock Inc. | 7.77M | 6.97M | 1.96% |
2023-06-29 | Citadel Advisors Llc | 5.35M | 4.80M | 1.35% |
2023-06-29 | PNC Financial Services Group, Inc. | 5.26M | 4.72M | 1.33% |
2023-06-29 | Millennium Management Llc | 4.65M | 4.17M | 1.17% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 10.28M | 9.22M | 2.59% |
2023-06-29 | Vanguard Small-Cap Index Fund | 9.15M | 8.21M | 2.30% |
2023-06-29 | Vanguard Small-Cap Growth Index Fund | 5.24M | 4.70M | 1.32% |
2023-06-29 | Vanguard Extended Market Index Fund | 4.77M | 4.28M | 1.20% |
2023-05-30 | Fidelity Extended Market Index Fund | 1.70M | 1.44M | 0.43% |
2023-05-30 | Schwab Strategic Tr-Schwab U.S. Small Cap ETF | 1.37M | 1.16M | 0.34% |
$CLOV take a picture pre + 6%, then +5,4,3,2,1,0
$CLOV Big boys are working. 0.91 to 0.99 to 0.91 to 0.99 to 0.91….. dont play this game with them. Its dangerous. Be patient
$CLOV it’s resting
Come on 494 million ER what you want more nice ER with fuck stock market.
Make big profits, the stock must rise. $494 million
Good ER
Clove have 400 million come on buy yourself matha fakaaa
Very cheap any one can rize thes stock
Captain is sleeping to take off Tomrow will fly
🟢A $CLOV
A Clover Health
A (Q2) 2023
*Sales️$513.63 million ($490.82 million expected)
GREAT ER ️
NICE ER 🫂🫂🫂
🟢A $CLOV
A Clover Health
A (Q2) 2023
*Sales️$513.63 million ($490.82 million expected)
$CLOV check $FFIE
Only 0.13 cent so sad
25$ again wahoooo